Market news
Stocks and crypto headlines from Alpaca. Stored for 7 days. Total: 9800.
-
Cencora Reports Fiscal Q4 2026 Results and Provides Fiscal 2027 GuidanceCencora reported fiscal fourth-quarter 2026 revenue of $88.35 billion and adjusted earnings per share of $4.66, while providing fiscal 2027 adjusted EPS guidance of $19.40 to $19.75.
-
Cencora Consolidates Specialty Businesses Under New LeadershipCencora is restructuring its specialty operations by consolidating its specialty distribution, GPO, and oncology/retina MSO platforms under the leadership of Richard Tremonte.
-
Himalaya Shipping Ltd. Enters New Time Charter Agreements for Two VesselsHimalaya Shipping Ltd. has secured new time charter agreements for two of its vessels, effective November 3, 2026, replacing existing contracts.
-
Fitch Maintains Grifols Rating on Steady PerformanceFitch Ratings has affirmed its credit rating for Grifols, S.A., citing the company's steady operational performance.
-
Asker Healthcare Group Reports Q3 2026 Financial ResultsAsker Healthcare Group announced its Q3 2026 financial performance, highlighting 15% year-over-year sales growth and a 24% increase in adjusted EBITA.
-
Procimmo Shareholders Approve Merger with Vaudoise Real EstateShareholders of the real estate investment group Procimmo have approved a merger with Vaudoise Real Estate, a subsidiary of Vaudoise Assurances.
-
Sacyr Reports 9M 2026 Financial ResultsSacyr announced its nine-month 2026 financial results, highlighting an 87% increase in net profit and a 9% rise in EBITDA.
-
UBS Upgrades Soitec to Neutral and Raises Price TargetUBS upgraded Soitec's stock rating from "sell" to "neutral" and increased its price target to 130 euros, citing stronger-than-expected growth in the Photonics-SOI business.
-
Barclays Adjusts Price Target on Aptiv to $53Barclays has lowered its 12-month price target for Aptiv PLC shares from $60 to $53.
-
Safran Unit to Supply Propulsion System for Uvad's Falcon Supersonic UAVA Safran unit has entered into a partnership with Uvad Technologies to provide the propulsion system for the new Falcon supersonic drone.
-
RBC Raises Lonza Price Target to 820 CHFRBC analysts have increased their price target for Lonza Group AG shares from 760 CHF to 820 CHF.
-
Barry Callebaut Reports Fiscal 2025/26 Results and Strategic UpdatesBarry Callebaut reported fiscal 2025/26 volume of 2.11 million tonnes, a 0.7% decline, while announcing a 15-year partnership with Mondelez and board changes.
-
Cantor Fitzgerald Adjusts Price Target on Booking HoldingsCantor Fitzgerald has revised its price target for Booking Holdings Inc. (BKNG) following the company's recent financial disclosures.
-
OneDegree Partners with Munich Re for Digital Asset InsuranceOneDegree has entered into a multi-year partnership with Munich Re to launch 'OneInfinity,' a digital asset insurance product.
-
Munich Re Ventures Invests in Data Security Firm SentraMunich Re Ventures participated in an investment round for Sentra, a data security company, alongside Key1 Capital.
-
Covestro Partners with Adnoc Subsidiary on Energy and CO2 ManagementCovestro has entered into a cooperation agreement with a subsidiary of Adnoc to focus on energy and CO2 management initiatives.
-
Accor One Living Named Founding Partner for FHS Living Investment ForumAccor One Living has been confirmed as a founding partner for the upcoming FHS Living investment forum, scheduled to take place in Paris in February 2027.
-
PGE S.A. Receives Notification of Transactions by Person Closely Associated with Supervisory Board MemberPGE Polska Grupa Energetyczna S.A. announced the receipt of a notification regarding financial instrument transactions from PKO Bank Polski S.A., a party closely associated with Supervisory Board member Piotr Stolarczyk.
-
Meliá Hotels International Named Headline Partner for FHS LivingMeliá Hotels International has been announced as a headline partner for the FHS Living event, which focuses on the investment and development of living real estate sectors.
-
NewAmsterdam Pharma Reports Third Quarter 2026 Financial ResultsNewAmsterdam Pharma Company N.V. announced its financial results for the third quarter of 2026, reporting a loss of $0.14 per share.